Sexually Transmitted Diseases, Viral
Welcome,         Profile    Billing    Logout  
 124 Companies   161 Products   161 Products   116 Mechanisms of Action   11 Trials   2428 News 


«12...4567891011121314...4950»
  • ||||||||||  Victrelis (boceprevir) / Roche, Merck (MSD)
    Trial completion, Trial primary completion date:  Dutch Acute HCV in HIV Study (DAHHS) (clinicaltrials.gov) -  Apr 1, 2016   
    P2,  N=65, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jul 2014 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Aug 2015
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis (clinicaltrials.gov) -  Mar 22, 2016   
    P3,  N=331, Active, not recruiting, 
    Trial primary completion date: Apr 2009 --> Aug 2007 Recruiting --> Active, not recruiting | N=420 --> 331 | Trial primary completion date: Jun 2014 --> Dec 2016
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults (clinicaltrials.gov) -  Mar 21, 2016   
    P1/2,  N=39, Completed, 
    Recruiting --> Active, not recruiting | N=420 --> 331 | Trial primary completion date: Jun 2014 --> Dec 2016 Recruiting --> Completed
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  COMO: Cognition Study With HIV+ Patients (CTNPT 015) (clinicaltrials.gov) -  Mar 16, 2016   
    P0,  N=19, Terminated, 
    Trial primary completion date: Jan 2016 --> Aug 2016 N=25 --> 19 | Recruiting --> Terminated | Trial primary completion date: Nov 2015 --> Mar 2016; In 14 participants who had LP, very low level viremia was found in only 1
  • ||||||||||  Cytovene (ganciclovir) / Roche, Vistide (cidofovir) / Gilead
    Trial completion:  Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) (clinicaltrials.gov) -  Mar 12, 2016   
    P3,  N=61, Completed, 
    N=25 --> 19 | Recruiting --> Terminated | Trial primary completion date: Nov 2015 --> Mar 2016; In 14 participants who had LP, very low level viremia was found in only 1 No longer recruiting --> Completed
  • ||||||||||  Trial completion:  Utilization of HIV Clinical Services in Rural India (clinicaltrials.gov) -  Mar 9, 2016   
    P3,  N=1300, Completed, 
    No longer recruiting --> Completed Enrolling by invitation --> Completed
  • ||||||||||  HSV vaccine (GEN-003) / Genocea, Shionogi
    Trial completion:  Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) -  Mar 8, 2016   
    P2,  N=310, Completed, 
    Enrolling by invitation --> Completed Active, not recruiting --> Completed
  • ||||||||||  Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
    Trial completion, Enrollment change, Trial primary completion date:  INSPIRE: Alcohol Pharmacotherapy for HIV+ Prisoners (clinicaltrials.gov) -  Mar 8, 2016   
    P=N/A,  N=100, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=125 --> 100 | Trial primary completion date: Aug 2016 --> Aug 2015
  • ||||||||||  Trial completion:  Affect Management for Early Adolescents (clinicaltrials.gov) -  Mar 5, 2016   
    P2,  N=420, Completed, 
    Active, not recruiting --> Completed | N=125 --> 100 | Trial primary completion date: Aug 2016 --> Aug 2015 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care (clinicaltrials.gov) -  Mar 1, 2016   
    P=N/A,  N=167, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=240 --> 167 | Trial primary completion date: Jan 2016 --> Jun 2015
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  HIV Assessment in Fuyang, Anhui Province, China (clinicaltrials.gov) -  Feb 27, 2016   
    P=N/A,  N=111, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  HCV/HIV Coinfection: Antiviral Therapy and Fibrosis (clinicaltrials.gov) -  Feb 24, 2016   
    P=N/A,  N=1250, Completed, 
    N=40 --> 20 Recruiting --> Completed | Trial primary completion date: Oct 2018 --> Oct 2015
  • ||||||||||  Trial completion:  Progress Pediatric Study (clinicaltrials.gov) -  Feb 22, 2016   
    P=N/A,  N=840, Completed, 
    Active, not recruiting --> Completed | N=30 --> 54 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Adherence:  Medication Adherence in Human Immunodeficiency Virus (HIV) (clinicaltrials.gov) -  Feb 21, 2016   
    P=N/A,  N=33, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  topiramate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) -  Feb 17, 2016   
    P2,  N=4, Terminated, 
    Active, not recruiting --> Completed N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV.
  • ||||||||||  Trial completion, Enrollment change:  Vitamin D Supplements for HIV-positive Patients on cART (clinicaltrials.gov) -  Feb 12, 2016   
    P=N/A,  N=120, Completed, 
    N=60 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jan 2014; We terminated the study due to problems recruiting alcoholic subjects with HIV. Recruiting --> Completed | N=200 --> 120
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals (clinicaltrials.gov) -  Feb 10, 2016   
    P=N/A,  N=74, Completed, 
    Recruiting --> Completed | N=200 --> 120 Active, not recruiting --> Completed | N=100 --> 74 | Trial primary completion date: Jun 2016 --> Aug 2014
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System (clinicaltrials.gov) -  Feb 10, 2016   
    P=N/A,  N=20, Completed, 
    Active, not recruiting --> Completed | N=100 --> 74 | Trial primary completion date: Jun 2016 --> Aug 2014 Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Sep 2015 --> Jun 2015
  • ||||||||||  Selzentry (maraviroc) / ViiV Healthcare
    Enrollment change, Trial termination, Trial primary completion date:  Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) (clinicaltrials.gov) -  Feb 8, 2016   
    P4,  N=165, Terminated, 
    Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: Sep 2015 --> Jun 2015 N=330 --> 165 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Jun 2015; Because a higher rate of virological failures in study versus control arm.
  • ||||||||||  sodium phenylbutyrate / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Immune Reconstitution in HIV Disease (IREHIV) (clinicaltrials.gov) -  Feb 5, 2016   
    P2,  N=279, Completed, 
    N=330 --> 165 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Jun 2015; Because a higher rate of virological failures in study versus control arm. Active, not recruiting --> Completed | N=198 --> 279 | Trial primary completion date: Dec 2015 --> Aug 2015
  • ||||||||||  lopinavir/ritonavir / Generic mfg.
    Trial completion, Combination therapy:  PROTEKT: Kaletra in Combination With Antiretroviral Agents (clinicaltrials.gov) -  Feb 5, 2016   
    P=N/A,  N=531, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed